Clinical Trials Details

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

IRB Protocol Number

S2414

Clinical Trial Categories

• Lung Cancer

Contact

Clinical Trials at 910-715-2200

How to Participate

Eligibility: Men and women 18+ years old, with diagnosis of clinical stage II-IIIB non-small cell lung cancer, must have received at least two cycles of neoadjuvant platinum-based chemotherapy and anti-PD-1 or anti-PD-L1 therapy, must have received a complete resection within 84 days, and surgery must result in no residual disease.